Franklin Resources Inc Uni Qure N.V. Transaction History

Franklin Resources Inc

$346 Billion
Q3 2024

A detailed history of Franklin Resources Inc transactions in Uni Qure N.V. stock. As of the latest transaction made, Franklin Resources Inc holds 1,492,962 shares of QURE stock, worth $8.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,492,962

Holding current value

$8.73 Million

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.78 - $10.12 $5.64 Million - $15.1 Million	1,492,962 New	1,492,962 $7.36 Million
Q4 2020 Feb 10, 2021	SELL	$35.35 - $50.67 $8.48 Million - $12.2 Million	-239,978 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$35.98 - $47.66 $14.6 Million - $19.4 Million	-406,502 Reduced 62.88%	239,978 $8.84 Million
Q2 2020 Aug 13, 2020	BUY	$45.06 - $67.74 $605,426 - $910,154	13,436 Added 2.12%	646,480 $27.3 Million
Q1 2020 May 13, 2020	BUY	$40.01 - $73.97 $899,184 - $1.66 Million	22,474 Added 3.68%	633,044 $30 Million
Q4 2019 Feb 12, 2020	BUY	$37.13 - $74.62 $2.49 Million - $5 Million	67,020 Added 12.33%	610,570 $43.8 Million
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $4.75 Million - $9.27 Million	-120,650 Reduced 18.16%	543,550 $21.4 Million
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $5.71 Million - $8.89 Million	108,200 Added 19.46%	664,200 $51.9 Million
Q1 2019 May 14, 2019	BUY	$27.39 - $68.41 $9.45 Million - $23.6 Million	345,100 Added 163.63%	556,000 $33.2 Million
Q4 2018 Feb 12, 2019	SELL	$22.8 - $33.93 $2.29 Million - $3.41 Million	-100,400 Reduced 32.25%	210,900 $6.08 Million
Q3 2018 Nov 13, 2018	BUY	$29.75 - $43.08 $2.02 Million - $2.92 Million	67,800 Added 27.84%	311,300 $11.3 Million
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $5.35 Million - $9.73 Million	243,500 New	243,500 $9.2 Million

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $273M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Uni Qure N.V. Transaction History